학술논문

Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes
Document Type
Article
Source
In: Anti-Cancer Agents in Medicinal Chemistry. (Anti-Cancer Agents in Medicinal Chemistry, April 2022, 22(7):1278-1285)
Subject
Language
English
ISSN
18755992
18715206